Total Payments
$82,894
2024 Payments
$41,638
Companies
14
Transactions
81
Medicare Patients
521
Medicare Billing
$122,054

Payment Breakdown by Category

Consulting$49,602 (59.8%)
Other$14,840 (17.9%)
Travel$13,946 (16.8%)
Education$2,587 (3.1%)
Food & Beverage$1,920 (2.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $49,602 20 59.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,840 4 17.9%
Travel and Lodging $13,946 21 16.8%
Education $2,587 4 3.1%
Food and Beverage $1,920 32 2.3%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $32,406 16 $0 (2024)
Merck Sharp & Dohme LLC $17,470 12 $0 (2024)
AstraZeneca Pharmaceuticals LP $11,312 9 $0 (2023)
Seagen Inc. $6,568 2 $0 (2021)
Intuitive Surgical, Inc. $4,265 22 $0 (2022)
Genmab U.S., Inc. $2,651 3 $0 (2024)
BioNTech SE $2,200 1 $0 (2023)
CooperSurgical, Inc. $2,025 2 $0 (2022)
Aadi Bioscience, Inc. $1,914 3 $0 (2024)
Clovis Oncology, Inc. $1,785 2 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $41,638 26 GlaxoSmithKline, LLC. ($19,603)
2023 $11,595 6 GlaxoSmithKline, LLC. ($6,600)
2022 $6,044 10 GlaxoSmithKline, LLC. ($2,830)
2021 $16,901 10 AstraZeneca Pharmaceuticals LP ($8,220)
2020 $3,000 2 Clovis Oncology, Inc. ($1,700)
2019 $386.20 7 Intuitive Surgical, Inc. ($209.61)
2018 $3,330 20 Intuitive Surgical, Inc. ($2,930)

All Payment Transactions

81 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/18/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,270.00 General
Category: ONCOLOGY
12/18/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging Cash or cash equivalent $150.00 General
Category: ONCOLOGY
12/06/2024 Genmab U.S., Inc. Epkinly (Drug) Consulting Fee In-kind items and services $2,625.00 General
Category: Oncology
11/21/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $889.45 General
11/21/2024 GlaxoSmithKline, LLC. Travel and Lodging Cash or cash equivalent $603.56 General
11/21/2024 GlaxoSmithKline, LLC. Travel and Lodging Cash or cash equivalent $388.64 General
11/12/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging In-kind items and services $621.60 General
Category: ONCOLOGY
11/12/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging In-kind items and services $437.83 General
Category: ONCOLOGY
11/12/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging In-kind items and services $128.65 General
Category: ONCOLOGY
11/12/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Food and Beverage In-kind items and services $120.00 General
Category: ONCOLOGY
10/19/2024 Genmab U.S., Inc. Epkinly (Drug) Food and Beverage In-kind items and services $18.26 General
Category: Oncology
10/19/2024 Genmab U.S., Inc. Epkinly (Drug) Food and Beverage In-kind items and services $7.82 General
Category: Oncology
10/17/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,270.00 General
Category: ONCOLOGY
10/17/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging Cash or cash equivalent $150.00 General
Category: ONCOLOGY
09/24/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging In-kind items and services $752.70 General
Category: ONCOLOGY
09/24/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Travel and Lodging In-kind items and services $345.61 General
Category: ONCOLOGY
09/24/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Food and Beverage In-kind items and services $123.67 General
Category: ONCOLOGY
09/06/2024 GlaxoSmithKline, LLC. Travel and Lodging In-kind items and services $9,169.59 General
08/12/2024 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $5,600.00 General
07/26/2024 Aadi Bioscience, Inc. Consulting Fee Cash or cash equivalent $1,712.50 General
07/26/2024 Aadi Bioscience, Inc. Food and Beverage In-kind items and services $112.50 General
04/17/2024 Merck Sharp & Dohme LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,100.00 General
03/16/2024 Aadi Bioscience, Inc. Fyarro (Drug) Food and Beverage In-kind items and services $89.00 General
Category: Cancer
02/22/2024 GlaxoSmithKline, LLC. ZEJULA (Drug) Consulting Fee Cash or cash equivalent $2,800.00 General
Category: ONCOLOGY
01/24/2024 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $123.60 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 136 183 $100,400 $29,960
2022 6 138 188 $110,344 $33,699
2021 6 141 169 $111,445 $34,921
2020 5 106 146 $78,186 $23,474
Total Patients
521
Total Services
686
Medicare Billing
$122,054
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less Facility 2023 14 14 $37,739 $10,532 27.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 33 33 $20,190 $6,028 29.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 44 $13,952 $4,865 34.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 24 32 $14,401 $4,615 32.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 39 60 $14,118 $3,920 27.8%
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less Facility 2022 18 18 $46,472 $13,312 28.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 27 53 $16,710 $5,750 34.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 32 32 $18,965 $5,459 28.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 16 25 $10,805 $3,806 35.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 33 48 $10,624 $3,407 32.1%
38900 Imaging of lymph nodes during surgery Facility 2022 12 12 $6,768 $1,964 29.0%
58571 Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope Facility 2021 22 22 $53,812 $16,124 30.0%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 38 38 $21,972 $7,245 33.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 22 38 $11,970 $3,952 33.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 18 21 $9,084 $3,241 35.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 30 39 $8,603 $2,659 30.9%
38900 Lymph node imaging during surgery Facility 2021 11 11 $6,005 $1,700 28.3%
58571 Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope Facility 2020 13 13 $33,018 $9,981 30.2%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 36 36 $19,426 $6,152 31.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 20 39 $11,273 $3,192 28.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 24 42 $8,153 $2,407 29.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 13 16 $6,316 $1,742 27.6%

About Dr. Fernanda Musa, M.D

Dr. Fernanda Musa, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700044054.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernanda Musa, M.D has received a total of $82,894 in payments from pharmaceutical and medical device companies, with $41,638 received in 2024. These payments were reported across 81 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($49,602).

As a Medicare-enrolled provider, Musa has provided services to 521 Medicare beneficiaries, totaling 686 services with total Medicare billing of $122,054. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

Practice Information

Products in Payments

  • ZEJULA (Drug) $14,807
  • LYNPARZA (Biological) $11,370
  • LYNPARZA (Drug) $8,539
  • Da Vinci Surgical System (Device) $3,265
  • Epkinly (Drug) $2,651
  • Advincula Delineator Uterine Manipulator (Device) $2,025
  • Rubraca (Drug) $1,785
  • DAVINCI XI (Device) $1,000
  • Fyarro (Drug) $89.00
  • PROCLAIM (Device) $29.88
  • CALDOLOR (Drug) $28.25
  • FOUNDATIONONE (Device) $23.68
  • Proclaim IPG (Device) $12.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Seattle